<DOC>
	<DOCNO>NCT02224911</DOCNO>
	<brief_summary>This pilot , feasibility/exploratory study evaluate safety laser interstitial thermal therapy ( LITT ) use Visualase focal treatment localized prostate cancer well gather data design future study .</brief_summary>
	<brief_title>Use Laser Interstitial Thermal Therapy Focal Treatment Localized Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Subjects initial presentation organ confine prostate cancer ( clinical stage ≤ T2b ) Negative metastatic workup bone scan CT abdomen/pelvis , within 6 month study treatment , indicate PSA &gt; 10 Age 40 year 85 year age Multiparametric MRI UCLA within 6 month study treatment , demonstrate Region interest ( ROI ) MRI suspicion level 3 high ROI locate proximal external sphincter margin least 2 cm Transrectal ultrasoundguided biopsy ≥ 10 systematic biopsy core ≥ 2 MRIultrasound fusion target biopsy core MRIderived ROI Histologicallyconfirmed adenocarcinoma target biopsy core ( ≥ 2 core ) Overall Gleason score exceed 3+4 Subjects desire focal therapy decline conventional treatment ( active surveillance , radical prostatectomy , radiation therapy , cryosurgery hormone therapy ) Signed informed consent LITT treatment 12 month follow visit Any significant cancer outside MRI target ( ROI ) area , define Gleason score &gt; 3+4 &lt; 10 year life expectancy American Society Anesthesiologists ( ASA ) criterion IV high Unfit conscious sedation anesthesia Active bleed disorder determine abnormal prothrombin time , partial thromboplastin time , INR platelet count ( determined institutional lab parameter ) time screen Use coumadin anticoagulant , unless anticoagulation temporarily reverse stop window least 7 day periprocedure Active urinary tract infection Prostate abscess , chronic acute prostatitis , neurogenic bladder Any prior treatment prostate cancer Radical prostatectomy Radiation therapy ( external beam brachytherapy ) Cryotherapy High intensity focus ultrasound treatment Photodynamic therapy Androgen deprivation therapy Prior prostate , bladder neck , urethral stricture surgery Any prostate debulking procedure , include : transurethral resection prostate , photovaporization , electrovaporization Transurethral incision bladder neck Urethral stricture dilation reconstruction Any current 5alpha reductase inhibitor ( history use ≥ 6 month prior MRI acceptable ) Prior significant rectal surgery ( hemorrhoidectomy acceptable ) Rectal fissure , fibrosis , stenosis , anatomic abnormality preclude insertion transrectal device History inflammatory bowel disease Urinary tract rectal fistula Any contraindication MRI ( contrast allergy severe claustrophobia , MRIincompatible prosthesis )</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>focal therapy</keyword>
	<keyword>prostate cancer treatment</keyword>
	<keyword>laser treatment</keyword>
</DOC>